financetom
Business
financetom
/
Business
/
MediWound Gets FDA Approval for Severe Thermal Burn Treatment for Pediatric Patients
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
MediWound Gets FDA Approval for Severe Thermal Burn Treatment for Pediatric Patients
Aug 16, 2024 1:54 AM

03:23 AM EDT, 08/16/2024 (MT Newswires) -- MediWound ( MDWD ) said late Thursday the US Food and Drug Administration has approved NexoBrid for the treatment of pediatric patients with severe thermal burns.

With the approval, the drug is now available for use by all age groups in the US, the company said.

Price: 17.76, Change: -0.41, Percent Change: -2.26

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Copyright 2023-2026 - www.financetom.com All Rights Reserved